Long-term management of plaque psoriasis with continuous efalizumab therapy.
Baylor University Medical Center, Dallas, Texas, USA. amresearch@texasderm.com
Alan
A
Menter
Craig L
CL
Leonardi
Wolfram
W
Sterry
Jan D
JD
Bos
Kim A
KA
Papp
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D002986:Clinical Trials as Topic; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D011565:Psoriasis / Q000188:drug therapy*; D011788:Quality of Life; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; C472181:efalizumab